Header cover image

Global Pharmaceuticals & Biotech Buy the Dip

UPDATED Jul 03, 2022

Companies which may present a buying opportunity after a dip in share price.

270 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
CURACuraleaf HoldingsCA$6.51-2.7%-62.3%CA$4.6bCA$19.14PS2.8xE74.2%n/a
CNWco.don€0.6361.5%-80.1%€13.8m€6.30PS2.1xE74.2%n/a
CHRSCoherus BioSciencesUS$7.834.4%-43.0%US$606.2mUS$18.75PS2xE71.5%n/a
BHVNBiohaven Pharmaceutical HoldingUS$145.311.1%45.6%US$10.3bUS$158.35PS14xE71.4%n/a
MITRAMithra Pharmaceuticals€6.95-17.1%-69.1%€347.2m€25.43PS15.3xE83.0%0%
CTICCTI BioPharmaUS$6.084.5%133.8%US$662.5mUS$9.58PS288.7xE68.1%n/a
FOLDAmicus TherapeuticsUS$10.80-2.9%11.5%US$3.0bUS$14.50PS9.5xE71.2%n/a
300841Chengdu Kanghua Biological ProductsCN¥118.2710.4%-34.1%CN¥15.6bCN¥158.78PE18.4xE27.8%0.8%
KZAKazia TherapeuticsAU$0.61-0.8%-55.3%AU$85.3mAU$1.90PS5.6xE59.5%n/a
ADMAADMA BiologicsUS$2.034.6%31.0%US$398.6mUS$4.75PS4.2xE66.9%n/a
CDXCChromaDexUS$1.67-13.0%-82.3%US$114.4mUS$7.91PS1.6xE68.6%n/a
RCUSArcus BiosciencesUS$26.503.7%-3.0%US$1.9bUS$57.20PE33.1xE47.1%n/a
ACADACADIA PharmaceuticalsUS$14.37-1.8%-40.9%US$2.3bUS$22.47PS4.7xE78.6%n/a
OPTNOptiNoseUS$3.643.1%21.7%US$301.0mUS$7.50PS3.9xE68.4%n/a
524348Aarti Drugs₹397.601.2%-45.4%₹36.8b₹477.00PE18xE23.1%0.3%
CLBIOCorline Biomedicalkr9.78-3.6%-15.3%kr210.2mkr30.00PS11.1xE119.4%n/a
HZNPHorizon TherapeuticsUS$80.84-5.4%-15.7%US$18.6bUS$138.64PE21.6xE24.3%n/a
AVIRAtea PharmaceuticalsUS$7.302.5%-68.6%US$607.8mUS$10.25PE12.6xE45.3%n/a
ICPTIntercept PharmaceuticalsUS$14.134.8%-29.3%US$419.8mUS$26.93PS1.1xE73.8%n/a
IMMImmutepAU$0.323.2%-39.6%AU$264.8mAU$1.25PS73.2xE62.9%n/a
300406Beijing Strong BiotechnologiesCN¥18.073.0%-12.3%CN¥10.2bn/aPE27.2xE27.6%0.6%
300601Shenzhen Kangtai Biological ProductsCN¥46.266.1%-50.4%CN¥50.0bCN¥57.75PE34.3xE27.6%1.6%
1801Innovent BiologicsHK$38.007.0%-57.3%HK$51.2bHK$48.79PS11.1xE58.8%n/a
BONEXBonesupport Holdingkr71.504.7%-6.5%kr4.6bkr91.00PS19.7xE111.6%n/a
Page 1 of 12